Blair William & CO Albireo Pharma, Inc. Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$18.01 - $23.78 $1,350 - $1,783	75 Added 0.49%	15,456 $334,000
Q3 2022 Nov 09, 2022	SELL	$16.32 - $26.37 $366,465 - $592,138	-22,455 Reduced 59.35%	15,381 $298,000
Q2 2022 Aug 10, 2022	SELL	$18.54 - $37.29 $334,368 - $672,525	-18,035 Reduced 32.28%	37,836 $751,000
Q1 2022 May 13, 2022	SELL	$23.94 - $33.74 $406,189 - $572,466	-16,967 Reduced 23.29%	55,871 $1.67 Million
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $228,322 - $337,149	-10,775 Reduced 12.89%	72,838 $1.7 Million
Q3 2021 Nov 12, 2021	BUY	$27.36 - $35.98 $631,222 - $830,094	23,071 Added 38.11%	83,613 $2.61 Million
Q2 2021 Aug 12, 2021	BUY	$28.9 - $36.87 $32,281 - $41,183	1,117 Added 1.88%	60,542 $2.13 Million
Q1 2021 May 13, 2021	BUY	$32.03 - $42.85 $177,830 - $237,903	5,552 Added 10.31%	59,425 $2.1 Million
Q4 2020 Feb 09, 2021	BUY	$31.56 - $42.16 $191,222 - $255,447	6,059 Added 12.67%	53,873 $2.02 Million
Q3 2020 Nov 06, 2020	BUY	$23.19 - $41.61 $254,394 - $456,461	10,970 Added 29.77%	47,814 $1.6 Million
Q2 2020 Aug 12, 2020	SELL	$14.82 - $29.92 $53,085 - $107,173	-3,582 Reduced 8.86%	36,844 $976,000
Q1 2020 May 11, 2020	BUY	$11.67 - $27.23 $15,614 - $36,433	1,338 Added 3.42%	40,426 $662,000
Q4 2019 Feb 13, 2020	SELL	$16.92 - $28.96 $132,432 - $226,669	-7,827 Reduced 16.68%	39,088 $994,000
Q3 2019 Nov 12, 2019	SELL	$20.0 - $31.88 $23,900 - $38,096	-1,195 Reduced 2.48%	46,915 $938,000
Q2 2019 Aug 13, 2019	BUY	$30.67 - $37.86 $580,000 - $715,970	18,911 Added 64.77%	48,110 $1.55 Million
Q1 2019 May 14, 2019	BUY	$22.22 - $32.21 $37,262 - $54,016	1,677 Added 6.09%	29,199 $940,000
Q4 2018 Feb 14, 2019	BUY	$20.9 - $32.57 $575,209 - $896,391	27,522 New	27,522 $675,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account